000 | 01936 a2200517 4500 | ||
---|---|---|---|
005 | 20250517001831.0 | ||
264 | 0 | _c20150923 | |
008 | 201509s 0 0 eng d | ||
022 | _a1433-7339 | ||
024 | 7 |
_a10.1007/s00520-014-2486-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBerenson, James R | |
245 | 0 | 0 |
_aA phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma. _h[electronic resource] |
260 |
_bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _cJun 2015 |
||
300 |
_a1503-12 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBenzhydryl Compounds _xadverse effects |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aFatigue _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aModafinil |
650 | 0 | 4 |
_aMultiple Myeloma _xcomplications |
650 | 0 | 4 | _aPlacebo Effect |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 |
_aWakefulness _xdrug effects |
650 | 0 | 4 |
_aWakefulness-Promoting Agents _xtherapeutic use |
700 | 1 | _aYellin, Ori | |
700 | 1 | _aShamasunder, Hesaraghatta K | |
700 | 1 | _aChen, Chien-Shing | |
700 | 1 | _aCharu, Veena | |
700 | 1 | _aWoliver, Thomas B | |
700 | 1 | _aSanani, Shamel | |
700 | 1 | _aSchlutz, Michael | |
700 | 1 | _aNassir, Youram | |
700 | 1 | _aSwift, Regina A | |
700 | 1 | _aAndreu-Vieyra, Claudia | |
700 | 1 | _aVescio, Robert | |
773 | 0 |
_tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _gvol. 23 _gno. 6 _gp. 1503-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00520-014-2486-7 _zAvailable from publisher's website |
999 |
_c24329672 _d24329672 |